Which vascular access device would you want if you were a patient?
According to a randomly selected, blinded U.S. national survey conducted by Bard Access Systems, Inc., 93% of responding oncology nurses surveyed ranked ports as their chemotherapy delivery method of choice.
The VEINS FOR LIFE* awareness program was created to help you and other oncology clinicians:
- Understand the advantages and disadvantages of ports and other I.V. chemotherapy delivery options
- Educate patients on how ports work and how they may help to positively impact a patient’s lifestyle and comfort
- Hear from patients who share their experiences on how an implanted port has helped them in their therapy
Matching the Appropriate Access Device to Patients’ Treatment Needs
To help you decide on whether an implanted port or another vascular access device is right for your chemotherapy patients—and assist you in educating patients about available chemotherapy delivery options—visit www.VEINS4LIFE.com. A port can take your patient from the beginning to the end of treatment.
Reference 1.Bard Access Systems Blinded Mail Survey with Oncology Nurses 2008. At the request of Bard Access Systems, Inc., the Oncology Nursing Society randomly selected 1,000 names from its mailing list. From the 1,000 randomly selected names, Bard Access Systems, Inc., selected 200 names. A total of 134 surveys were received. The net response rate was 74%. Data on file at Bard Access Systems, Inc., Salt Lake City, Utah.